Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Breast Neoplasms 6Prostatic Neoplasms 3Neoplasms 3Motor Activity 3Pancreatic Neoplasms 2Overweight 2Obesity 2Malnutrition 2Lung Neoplasms 2Colorectal Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Taste Disorders 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcopenia 1Rectal Neoplasms 1Patient Compliance 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Metabolic Diseases 1Lymphoma 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Hypertension 1Hypercholesterolemia 1Heart Failure 1Heart Diseases 1Esophageal Neoplasms 1

Interventions

pembrolizumab 45Paclitaxel 42Carboplatin 34Bevacizumab 18Specimen Handling 17Letrozole 16lenvatinib 13Magnetic Resonance Spectroscopy 12dostarlimab 11Cisplatin 11Biopsy 11Taxes 10olaparib 9Fulvestrant 9Doxorubicin 9abemaciclib 8Megestrol Acetate 8Docetaxel 8durvalumab 7atezolizumab 7Nivolumab 7Gemcitabine 7Blood Specimen Collection 7palbociclib 6Oxaliplatin 6Observation 6Fluorouracil 6niraparib 5Surveys and Questionnaires 5Progestins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Nutrition Assessment × 1 year × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡